Navigation Links
Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
Date:11/12/2008

- Not Intended for Journalists in the UK or Ireland - New Findings From ARTEMIS and TITAN Studies Demonstrate Growth of the

Tibotec Virology Franchise

GLASGOW, Scotland, Nov. 12 /PRNewswire/ -- New data on PREZISTA(R) (darunavir), a protease inhibitor from Tibotec, will be presented at the Ninth International Congress on Drug Therapy in HIV Infection (HIV9) in Glasgow, U.K., from 09-13 November 2008. The company also presented new data on PREZISTA(R) at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C., from 25-28 October 2008. These presentations follow key regulatory approvals and decisions for PREZISTA(R) and INTELENCE(TM) (etravirine), a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI). The company continues to research various compounds in hepatitis C, tuberculosis and HIV.

"The Tibotec data being presented at HIV9 culminate an exciting three months for the company and for the entire HIV community," said Roger Pomerantz, President, Tibotec Research & Development. "The data we've amassed and the regulatory milestones we've achieved this year are signs of our dedication to finding innovative ways to meet the needs of people with HIV."

Recent Regulatory Milestones for Tibotec in HIV

- 28 August 2008 - The European Commission approved etravirine, in

combination with a boosted protease inhibitor and other antiretroviral

medicinal products, for the treatment of human immunodeficiency virus

type 1 (HIV-1) infection in antiretroviral treatment-experienced adult

patients.

- 21 October 2008 - The U.S. FDA granted traditional approval to

darunavir, coadministered with low dose ritonavir, for twice-daily use

in treatment-experienced adult patients, as well as an expanded

indication for once-daily dosing as part of HIV combination therapy in

treatment-na
'/>"/>

SOURCE Tibotec Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
2. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
3. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
4. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
7. Inhaled Nitric Oxide Data Presented at European Academy of Pediatrics Meeting
8. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
9. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
10. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
11. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... May 22, 2013   Life Line Screening ... announced today the creation of a unique partnership with ... MCM is a population health management organization. ... list of clients. These important expanded services will help ... earlier. Effective prevention reduces cost of care when individuals ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013 /PRNewswire/ ... creation firm focused on healthcare and sustainability, today ... as a Senior Partner. In this ... support to portfolio companies. In addition ... portfolio, Mr. Bancel also serves as President and ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Footwear etc. ... Dansko Vista Collection of sandals containing cork footbeds. Known ... has had consistently good sales for many years, and with ... spring and summer. , Dansko Shoes and ... the Vista Collection is no exception. Containing leather and patent ...
(Date:5/23/2013)... Shirataki noodles are growing in ... a diet strategy. These noodles are originally from Japan ... When losing weight, diet and exercise are the two ... dieters not only research shirataki noodles but offers tons ... buy them. Shirataki noodles are very healthy ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... 2013 Catalyst Exhibits, Inc., an award-winning ... feature to its website that allows visitors to ... through an immersive, 360-degree, interactive experience. , The ... ability to virtually experience the exhibit design Catalyst created ... and services. Users have the ability to interact with ...
Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2
... claimed that they have developed a vaccine against two ... question can easily kill humans and could potentially be ... viruses is that Hendra virus emerged in 1994, killing ... in Brisbane. Thereafter the trainer of Vo Rogue, died ...
... study has now proved that acupuncture, even sham acupuncture may ... migraine//. A comparable level of treatment efficacy has been documented ... with respect to reduction in migraine days. ,More ... for the study. The study participants who had two to ...
... investigate the possibility of building the labs across the world ... to invest $1.9bn from various developed countries where the investigation ... ,Tony Blair while facing questions in the House of Commons ... insisted that precautions were adequate. He proposed to set up ...
... the University of California, Irvine (UCI) and also the ... drug// AF267B is effective against both forms of brain ... ,This compound (AF267B) curbs both the amyloid protein plaques ... lesion, the tangles of protein called tau. ...
... Cancer researcher Philippa Darbre, PhD, of the University of Reading ... the use of deodorants or antiperspirants and breast cancer. She ... mimics estrogen in the body.// ,"Lifetime exposure to ... to breast cancer," Darbre said. "If the aluminum salts in ...
... bewildered as about 3,000 people in the steel town were affected ... reported in a small group at a slum// cluster in Panposh ... Since then, it has rapidly spread to other parts of the ... and acute colic pain, said a senior district health official. ...
Cached Medicine News:Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: